Use of chlormethine 0.04% gel for mycosis fungoides after treatment with topical chlormethine 0.02% gel: A phase 2 extension study.

Querfeld, Christiane; Kim, Youn H; Guitart, Joan; Scarisbrick, Julia; Quaglino, Pietro

Querfeld, Christiane; Kim, Youn H; Guitart, Joan; Scarisbrick, Julia; Quaglino, Pietro.

Afiliação

Querfeld C; City of Hope Comprehensive Cancer Center, Duarte, California. Electronic address: cquerfeld@coh.org.
Kim YH; Department of Dermatology, Stanford Cancer Center, Stanford, California.
Guitart J; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Scarisbrick J; University of Birmingham, Birmingham, United Kingdom.
Quaglino P; University of Turin, Turin, Italy.

J Am Acad Dermatol ; 87(1): 209-211, 2022 07.

Article em En | MEDLINE | ID: mdl-34333079

Assuntos

Micose Fungoide; Neoplasias Cutâneas; Géis; Humanos; Mecloretamina; Micose Fungoide/tratamento farmacológico; Neoplasias Cutâneas/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Micose Fungoide Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google